Consolidation is likely to continue, with the indices attempting to defend the previous Thursday’s low in the upcoming ...

The stock's fall snapped a four-day winning streak.

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Pfizer shares climbed Tuesday after two punchy headlines hit the wire. FDA advisors are considering COVID-19 vaccines for ...

BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer Inc. (NYSE:PFE) and kept the price target the same at ...

Pfizer closes a deal on a new Cancer drug. The stock is pacing for 4th day of gains. The Investment Committee debate the ...

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

According to Benzinga Pro, Pfizer's peer group average for short interest as a percentage of float is 3.60%, which means the ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

The highest dividend-paying stocks in the S&P 500 right now are blue-chip stocks that yield anywhere between 6.2% and 9.3% annually. And while markets are largely flat since Jan. 1 — with a ...